Global Human Microbiome Market

The global Human MicrobiomeMarketwas valued at USD 160.57 million in 2016 and is projected to reach USD 899.40million by 2025, growing at a CAGR of 21.10% from 2017 to 2025.
The human microbiota or microbiome is the aggregate of microorganisms that resides on or within any of a number of human tissues and biofluids, including the skin, mammary glands, placenta, seminal fluid etc.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increased Focus on Human Microbiome Therapy
1.2 Human Microbiome as New Validated Target for Drug Development
1.3 Human Microbiome for Early Disease Detection and Diagnosis

2. Market Restraints
2.1 Lack of Expertise
2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease

Market Segmentation:
1. Global Human MicrobiomeMarket, by Product:
1.1 Instruments
1.1.1 Laboratory Instruments
1.1.2 Analyzers
1.2 Consumables
1.2.1 Kits
1.2.2 Reagents

2. Global Human MicrobiomeMarket, by Technology:
2.1 Cell Culture Technology
2.2 High-Throughput Technology
2.3 Omics Technology
2.4 Computational Tools

3. Global Human MicrobiomeMarket, by Disease:
3.1 Acute Diarrhea
3.2 Obesity
3.3 Diabetes
3.4 Autoimmune Disorders
3.5 Cancer
3.6 Mental Disorders
3.7 Other Diseases

4. Global Human Microbiome Market, by Application:
4.1 Therapeutics
4.2 Diagnostics

5. Global Human Microbiome Market, by Product type:
5.1 Probiotics
5.2 Foods
5.3 Prebiotics
5.4 Medical Foods
5.5 Diagnostic Devices
5.6 Drugs
5.7 Other Probiotic Supplements

6. Global Human Microbiome Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Enterome Bioscience
2. E.I. Du Pont De Nemours and Company
3. Merck & Co., Inc.
4. Metabiomics Corporation
5. Yakult Honsha Co., Ltd.
6. Microbiome Therapeutics, LLC
7. Osel, Inc.
8. Second Genome, Inc.
9. Vithera Pharmaceuticals
10. Vedanta Biosciences, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Human MicrobiomeMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.